NAD(P)H: Quinone Oxidoreductase 1 is Induced by Progesterone in Cardiomyocytes

[1]  Qin M. Chen,et al.  Inhibition of apoptosis by progesterone in cardiomyocytes , 2010, Aging cell.

[2]  C. B. Pickett,et al.  The Nrf2-Antioxidant Response Element Signaling Pathway and Its Activation by Oxidative Stress* , 2009, Journal of Biological Chemistry.

[3]  C. Gibson,et al.  Is Progesterone a Candidate Neuroprotective Factor for Treatment following Ischemic Stroke? , 2009, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[4]  Shyam Biswal,et al.  Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. , 2007, Annual review of pharmacology and toxicology.

[5]  J. Kotwica,et al.  Effect of progesterone on the expression of bax and bcl-2 and on caspase activity in bovine luteal cells. , 2005, Prostaglandins & other lipid mediators.

[6]  Qin M. Chen,et al.  Corticosteroids Inhibit Cell Death Induced by Doxorubicin in Cardiomyocytes: Induction of Antiapoptosis, Antioxidant, and Detoxification Genes , 2005, Molecular Pharmacology.

[7]  N. Baquer,et al.  Administration of estradiol and progesterone modulate the activities of antioxidant enzyme and aminotransferases in naturally menopausal rats , 2005, Experimental Gerontology.

[8]  M. Paquet,et al.  Lower induction of p53 and decreased apoptosis in NQO1-null mice lead to increased sensitivity to chemical-induced skin carcinogenesis. , 2005, Cancer research.

[9]  O. Erel,et al.  The association of total antioxidant capacity with sex hormones , 2005, Scandinavian cardiovascular journal : SCJ.

[10]  Sushil K. Jain,et al.  Protective effects of 17β-estradiol and trivalent chromium on interleukin-6 secretion, oxidative stress, and adhesion of monocytes: Relevance to heart disease in postmenopausal women , 2004 .

[11]  K. Okuda,et al.  Progesterone Is a Suppressor of Apoptosis in Bovine Luteal Cells1 , 2004, Biology of reproduction.

[12]  C. Sites,et al.  Progesterone stimulates cardiac muscle protein synthesis via receptor-dependent pathway. , 2004, Fertility and sterility.

[13]  A. Bohdanowicz-Pawlak,et al.  Serum lipid peroxides and total antioxidant status in postmenopausal women on hormone replacement therapy , 2004, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[14]  P. Singal,et al.  Adriamycin-induced heart failure: mechanisms and modulation , 2000, Molecular and Cellular Biochemistry.

[15]  L. Prouty,et al.  Protective effects of 17beta-estradiol and trivalent chromium on interleukin-6 secretion, oxidative stress, and adhesion of monocytes: relevance to heart disease in postmenopausal women. , 2004, Free Radical Biology & Medicine.

[16]  I. Chaudry,et al.  Progesterone administration after trauma and hemorrhagic shock improves cardiovascular responses. , 2003, Critical Care Medicine.

[17]  P. Palatini,et al.  Oral administration of trans-resveratrol to guinea pigs increases cardiac DT-diaphorase and catalase activities, and protects isolated atria from menadione toxicity. , 2003, Life sciences.

[18]  David Siegel,et al.  Interaction of Human NAD(P)H:Quinone Oxidoreductase 1 (NQO1) with the Tumor Suppressor Protein p53 in Cells and Cell-free Systems* , 2003, The Journal of Biological Chemistry.

[19]  M. Schumacher,et al.  Basis of progesterone protection in spinal cord neurodegeneration , 2002, The Journal of Steroid Biochemistry and Molecular Biology.

[20]  J. Lotem,et al.  NQO1 stabilizes p53 through a distinct pathway , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[21]  S. Ozden,et al.  The effects of hormone replacement therapy on lipid peroxidation and antioxidant status. , 2001, Maturitas.

[22]  R. Dahiya,et al.  Paracrine regulation of apoptosis by steroid hormones in the male and female reproductive system , 2001, Cell Death and Differentiation.

[23]  A. Bohdanowicz-Pawlak,et al.  Serum lipid peroxide levels and erythrocyte glutathione peroxidase and superoxide dismutase activity in premenopausal and postmenopausal women , 2001, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[24]  A. Knowlton,et al.  Heat-shock factor-1, steroid hormones, and regulation of heat-shock protein expression in the heart. , 2001, American journal of physiology. Heart and circulatory physiology.

[25]  P. Gutiérrez.  The role of NAD(P)H oxidoreductase (DT-Diaphorase) in the bioactivation of quinone-containing antitumor agents: a review. , 2000, Free radical biology & medicine.

[26]  A. Dinkova-Kostova,et al.  Persuasive evidence that quinone reductase type 1 (DT diaphorase) protects cells against the toxicity of electrophiles and reactive forms of oxygen. , 2000, Free radical biology & medicine.

[27]  M. Runge,et al.  Doxorubicin-Induced Cardiomyopathy , 2000 .

[28]  E. Hall,et al.  Gender differences in acute CNS trauma and stroke: neuroprotective effects of estrogen and progesterone. , 2000, Journal of neurotrauma.

[29]  Y. J. Kang,et al.  Overexpression of metallothionein in the heart of transgenic mice suppresses doxorubicin cardiotoxicity. , 1997, The Journal of clinical investigation.

[30]  G. Buonocore,et al.  Effects of estradiol and medroxyprogesterone-acetate treatment on erythrocyte antioxidant enzyme activities and malondialdehyde plasma levels in amenorrhoic women. , 1997, The Journal of clinical endocrinology and metabolism.

[31]  Michael Chopp,et al.  Progesterone is neuroprotective after transient middle cerebral artery occlusion in male rats , 1996, Brain Research.

[32]  Y. J. Kang,et al.  Suppression of Doxorubicin Cardiotoxicity by Overexpression of Catalase in the Heart of Transgenic Mice (*) , 1996, The Journal of Biological Chemistry.

[33]  C. Romanini,et al.  Transdermal estradiol and medroxyprogesterone acetate in hormone replacement therapy are both antioxidants. , 1995, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[34]  L. Moore,et al.  Short‐Term Effects of Estrogen and Progestin on Blood Pressure of Normotensive Postmenopausal Women , 1991, Journal of clinical pharmacology.

[35]  G. Schuurhuis,et al.  Doxorubicin (adriamycin): a critical review of free radical-dependent mechanisms of cytotoxicity. , 1990, Pharmacology & therapeutics.

[36]  M. Nakano,et al.  Estrogens as natural antioxidants of membrane phospholipid peroxidation , 1987, FEBS letters.

[37]  J. Doroshow,et al.  Redox cycling of anthracyclines by cardiac mitochondria. I. Anthracycline radical formation by NADH dehydrogenase. , 1986, The Journal of biological chemistry.

[38]  J. Doroshow,et al.  Redox cycling of anthracyclines by cardiac mitochondria. II. Formation of superoxide anion, hydrogen peroxide, and hydroxyl radical. , 1986, The Journal of biological chemistry.

[39]  J. Studd,et al.  Natural progesterone and antihypertensive action , 1985, British medical journal.

[40]  R. Magorien,et al.  Early changes in human myocardial nuclei after doxorubicin , 1983, Cancer.

[41]  L. Ernster,et al.  DT-diaphorase as a quinone reductase: a cellular control device against semiquinone and superoxide radical formation. , 1982, Archives of biochemistry and biophysics.

[42]  H. Mcgill,et al.  Hormone Receptors of the Baboon Cardiovascular System: Biochemical Characterization of Aortic and Myocardial Cytoplasmic Progesterone Receptors , 1982, Circulation research.

[43]  K. Horwitz,et al.  Canine vascular tissues are targets for androgens, estrogens, progestins, and glucocorticoids. , 1982, The Journal of clinical investigation.

[44]  D. Williams,et al.  The effect of prolonged oral contraceptive steroid use on erythrocyte glutathione peroxidase activity. , 1981, Journal of steroid biochemistry.

[45]  P. Talalay,et al.  Increase of NAD(P)H:quinone reductase by dietary antioxidants: possible role in protection against carcinogenesis and toxicity. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[46]  Randolph P. Martin,et al.  Early anthracycline cardiotoxicity. , 1978, The American journal of medicine.

[47]  J. Pitha,et al.  A clinicopathologic analysis of adriamycin cardiotoxicity , 1973, Cancer.